ClinicalTrials.gg
Sign In

Squamous Intraepithelial Lesions clinical trials

The registry lists 103 studies for Squamous Intraepithelial Lesions across more than 10 countries. 35 are recruiting or about to start. 56 of them are mainly about Squamous Intraepithelial Lesions (how this is decided). Per ClinicalTrials.gov, last updated 2026-10-29. Counting its narrower condition Squamous Intraepithelial Lesions of the Cervix too: 108 studies, 39 open.

Get an email when these change. Save the Squamous Intraepithelial Lesions studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
45
Recruiting
22
Not yet recruiting
12
Status unknown
12
Terminated
6
Active, not recruiting
4

Phase

Phase 2
29
Phase 1
10
Phase 3
7
Phase 4
4
Early Phase 1
1

Where

United States
43
China
26
Puerto Rico
7
Spain
6
Belgium
5
South Africa
4

Who runs them

AIDS Malignancy Consortium (8) · Fujian Maternity and Child Health Hospital (5) · Antiva Biosciences (4) · Inovio Pharmaceuticals (4) · Lei Li (4) · Newish Biotech (Wuxi) Co., Ltd. (3) · Medtronic - MITG (2) · Tigris Pharmaceuticals (2)

What is being tested here

Drugs under test in Squamous Intraepithelial Lesions studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
NWRD09202
Imiquimod123
NWRD08102
Aminolevulinic Acid102
Probiotic101
Glycyrrhizic Acid101
VGX-3100024
Acyclic Nucleoside Phosphonate Prodrug ABI-1968004
Fluorouracil022
Cidofovir002

Coming up

2phase 3 studies under way
12studies finish main data collection within a year1 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest, phase 3 first

Who these studies take

Of the 22 Squamous Intraepithelial Lesions studies recruiting now, 10 (45%) set no upper age limit and 11 (50%) stop at 75 or younger. 3 (14%) take children under 18. 17 (77%) are for women only and 1 (5%) for men only; 7 (32%) take healthy volunteers.

Recruiting studies that take each age, of 22
AgeWomenMen
103 (14%)0 (0%)
1812 (55%)3 (14%)
3021 (95%)4 (18%)
4021 (95%)5 (23%)
5019 (86%)5 (23%)
6516 (73%)5 (23%)
7511 (50%)5 (23%)
8510 (45%)5 (23%)

Across all 103 studies, recruiting or not: 43% stop at 75 or younger and 36% at 65; 10% take children; 61% are for women only and 5% for men only; 16% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

What changed recently

From the registry's own updates since Oct 13, 2026.

Started recruiting2

Newly registered1

Studies

Recruiting first, then most recently updated. Showing 50 of 103. Browse all 103 → or search them.